Neurogene (NGNE) Shares Issued (2013 - 2020)

Neurogene's (NGNE) quarterly Shares Issued came in at $6.8 million in Q3 2020, up 588.26% on a QoQ basis from $983334.0 in Q2 2020.

Neurogene (NGNE) Shares Issued (2013 - 2020) Analysis & Trends

Neurogene (NGNE) has 8 years of Shares Issued data on file, last reported at $6.8 million in Q3 2020.

Quarterly Shares Issued changed N/A year-over-year to $6.8 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $6.8 million (changed N/A YoY) and the FY2019 annual result came in at $5.8 million, up 101.59% from the prior year.
Shares Issued climbed to $6.8 million in Q3 2020, from $983334.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $6.8 million in Q3 2020 to a low of $526197.0 in Q3 2016.
A 5-year average of $2.2 million and a median of $1.4 million in 2016 frame the typical range for Shares Issued.
Annual changes were most pronounced in 2017 — Shares Issued surged 294.06% — and 2019, when it plunged 61.05%.
Tracing NGNE's Shares Issued over 5 years: stood at $1.4 million in 2016, then soared by 50.12% to $2.1 million in 2017, then surged by 40.02% to $2.9 million in 2018, then jumped by 101.59% to $5.8 million in 2019, then grew by 15.88% to $6.8 million in 2020.
The last three Shares Issued figures came in at $6.8 million (Q3 2020), $983334.0 (Q2 2020), and $1.0 million (Q1 2020), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	18.36 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Neurogene	815.03 Mn	815.03 Mn	-	-

Download Data